Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

540 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A view from the acute hospital: managing patients with alcohol problems.
Pang D, Duffield P, Day E. Pang D, et al. Br J Hosp Med (Lond). 2019 Sep 2;80(9):500-506. doi: 10.12968/hmed.2019.80.9.500. Br J Hosp Med (Lond). 2019. PMID: 31498680 Review.
Buprenorphine in the treatment of opioid dependence.
George S, Day E. George S, et al. Br J Hosp Med (Lond). 2007 Nov;68(11):594-7. doi: 10.12968/hmed.2007.68.11.27681. Br J Hosp Med (Lond). 2007. PMID: 18087846 Review.
Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol.
Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Day E, et al. Cochrane Database Syst Rev. 2013 Jul 1;2013(7):CD004033. doi: 10.1002/14651858.CD004033.pub3. Cochrane Database Syst Rev. 2013. PMID: 23818100 Free PMC article. Review.
We compared the lowest dose (5 mg/day) with each of the other four doses. A significant difference favoured 200 mg/day compared with the 5-mg/day dose in determining the number of trials needed to meet inclusion criteria on a delayed alternation test (mean di …
We compared the lowest dose (5 mg/day) with each of the other four doses. A significant difference favoured 200 mg/day compare …
Alcohol and substance abuse in solid-organ transplant recipients.
Parker R, Armstrong MJ, Corbett C, Day EJ, Neuberger JM. Parker R, et al. Transplantation. 2013 Dec 27;96(12):1015-24. doi: 10.1097/TP.0b013e31829f7579. Transplantation. 2013. PMID: 24025323 Review.
A randomised controlled feasibility trial of family and social network intervention for young people who misuse alcohol and drugs: study protocol (Y-SBNT).
Watson J, Back D, Toner P, Lloyd C, Day E, Brady LM, Templeton L, Ambegaokar S, Parrott S, Torgerson D, Cocks K, Gilvarry E, McArdle P, Copello A. Watson J, et al. Pilot Feasibility Stud. 2015 Mar 13;1:8. doi: 10.1186/s40814-015-0004-4. eCollection 2015. Pilot Feasibility Stud. 2015. PMID: 27965788 Free PMC article.
Using this opportunity to compare the effectiveness of the intervention against treatment as usual, Timeline Follow-Back interviews will document the proportion of days on which the main problem substance was used in the preceding 90-day period at each assessment point. .. …
Using this opportunity to compare the effectiveness of the intervention against treatment as usual, Timeline Follow-Back interviews will doc …
Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial.
Watson J, Toner P, Day E, Back D, Brady LM, Fairhurst C, Renwick C, Templeton L, Akhtar S, Lloyd C, Li J, Cocks K, Ambegaokar S, Parrott S, McArdle P, Gilvarry E, Copello A. Watson J, et al. Health Technol Assess. 2017 Mar;21(15):1-260. doi: 10.3310/hta21150. Health Technol Assess. 2017. PMID: 28399988 Free PMC article. Clinical Trial.
The main clinical outcome was the proportion of days on which the main problem substance was used in the preceding 90-day period as captured by the Timeline Follow-Back interview at 3 and 12 months. ...
The main clinical outcome was the proportion of days on which the main problem substance was used in the preceding 90-day period as c …
Alcohol use disorders and the heart.
Day E, Rudd JHF. Day E, et al. Addiction. 2019 Sep;114(9):1670-1678. doi: 10.1111/add.14703. Epub 2019 Jul 15. Addiction. 2019. PMID: 31309639 Free PMC article.
Maximum potential benefit occurs at 0.5 to one standard drinks (7-14 g pure ethanol) per day for women (18% lower all-cause mortality, 95% confidence interval (CI) = 13-22%) and one to two standard drinks (14-28 g ethanol) per day for men (17% lower all-cause mortal …
Maximum potential benefit occurs at 0.5 to one standard drinks (7-14 g pure ethanol) per day for women (18% lower all-cause mortality …
A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services.
Day E, Copello A, Seddon JL, Christie M, Bamber D, Powell C, Bennett C, Akhtar S, George S, Ball A, Frew E, Goranitis I, Freemantle N. Day E, et al. BMC Psychiatry. 2018 Jan 15;18(1):8. doi: 10.1186/s12888-018-1600-7. BMC Psychiatry. 2018. PMID: 29334921 Free PMC article. Clinical Trial.
Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT.
Strang J, Kelleher M, Mayet S, Day E, Hellier J, Byford S, Murphy C, McLennan B, Shearer J, Ryan E, Marsden J. Strang J, et al. Health Technol Assess. 2019 Jan;23(3):1-72. doi: 10.3310/hta23030. Health Technol Assess. 2019. PMID: 30702059 Free PMC article. Clinical Trial.
INTERVENTIONS: One iGen/Atral-Cipan Extended Release Naltrexone device (iGen/Atral-Cipan, Castanheira do Ribatejo, Portugal) (765 mg naltrexone or placebo) at day 0 of study week 1. Three weekly directly observed active or placebo oral naltrexone tablets (2 × 50 mg, Monday …
INTERVENTIONS: One iGen/Atral-Cipan Extended Release Naltrexone device (iGen/Atral-Cipan, Castanheira do Ribatejo, Portugal) (765 mg naltrex …
540 results
Jump to page
Feedback